These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30646846)

  • 1. Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia.
    de Porto AP; Liu Z; de Beer R; Florquin S; de Boer OJ; Hendriks RW; van der Poll T; de Vos AF
    Mol Med; 2019 Jan; 25(1):3. PubMed ID: 30646846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruton's Tyrosine Kinase-Mediated Signaling in Myeloid Cells Is Required for Protective Innate Immunity During Pneumococcal Pneumonia.
    de Porto AP; Liu Z; de Beer R; Florquin S; Roelofs JJTH; de Boer OJ; den Haan JMM; Hendriks RW; van 't Veer C; van der Poll T; de Vos AF
    Front Immunol; 2021; 12():723967. PubMed ID: 34552589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Bruton's tyrosine kinase (BTK) inhibitor in the eosinophilic asthma model of mouse.
    Choi Y; Kim SH; Jun Shin S; Park HS; Seob Shin Y
    Int Immunopharmacol; 2024 May; 132():111903. PubMed ID: 38579561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bruton's tyrosine kinase (BTK) inhibitors alter blood glucose and insulin in obese mice but reduce inflammation independent of BTK.
    Chan DY; Barra NG; Fang H; Rodrigues E-Lacerda R; Schertzer JD
    Am J Physiol Endocrinol Metab; 2024 Sep; 327(3):E271-E278. PubMed ID: 39017678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment.
    Stiff A; Trikha P; Wesolowski R; Kendra K; Hsu V; Uppati S; McMichael E; Duggan M; Campbell A; Keller K; Landi I; Zhong Y; Dubovsky J; Howard JH; Yu L; Harrington B; Old M; Reiff S; Mace T; Tridandapani S; Muthusamy N; Caligiuri MA; Byrd JC; Carson WE
    Cancer Res; 2016 Apr; 76(8):2125-36. PubMed ID: 26880800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R-roscovitine reduces lung inflammation induced by lipoteichoic acid and Streptococcus pneumoniae.
    Hoogendijk AJ; Roelofs JJ; Duitman J; van Lieshout MH; Blok DC; van der Poll T; Wieland CW
    Mol Med; 2012 Sep; 18(1):1086-95. PubMed ID: 22692577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Bruton's tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia: a mechanistic study using patient-derived blast cells.
    Rushworth SA; Pillinger G; Abdul-Aziz A; Piddock R; Shafat MS; Murray MY; Zaitseva L; Lawes MJ; MacEwan DJ; Bowles KM
    Lancet Haematol; 2015 May; 2(5):e204-11. PubMed ID: 26688095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid liver kinase B1 contributes to lung inflammation induced by lipoteichoic acid but not by viable Streptococcus pneumoniae.
    Pereverzeva L; Otto NA; Roelofs JJTH; de Vos AF; van der Poll T
    Respir Res; 2022 Sep; 23(1):241. PubMed ID: 36096803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fcγ Receptor (FcγR) Function.
    Ren L; Campbell A; Fang H; Gautam S; Elavazhagan S; Fatehchand K; Mehta P; Stiff A; Reader BF; Mo X; Byrd JC; Carson WE; Butchar JP; Tridandapani S
    J Biol Chem; 2016 Feb; 291(6):3043-52. PubMed ID: 26627823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice.
    O'Riordan CE; Purvis GSD; Collotta D; Chiazza F; Wissuwa B; Al Zoubi S; Stiehler L; Martin L; Coldewey SM; Collino M; Thiemermann C
    Front Immunol; 2019; 10():2129. PubMed ID: 31552054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting Bruton's tyrosine kinase rescues mice from lethal influenza-induced acute lung injury.
    Florence JM; Krupa A; Booshehri LM; Davis SA; Matthay MA; Kurdowska AK
    Am J Physiol Lung Cell Mol Physiol; 2018 Jul; 315(1):L52-L58. PubMed ID: 29516781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bruton's tyrosine kinase (BTK) as a promising target in solid tumors.
    Molina-Cerrillo J; Alonso-Gordoa T; Gajate P; Grande E
    Cancer Treat Rev; 2017 Jul; 58():41-50. PubMed ID: 28641100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B lymphocytes inactivation by Ibrutinib limits endometriosis progression in mice.
    Riccio LGC; Jeljeli M; Santulli P; Chouzenoux S; Doridot L; Nicco C; Reis FM; Abrão MS; Chapron C; Batteux F
    Hum Reprod; 2019 Jul; 34(7):1225-1234. PubMed ID: 31247078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous MCP-1 promotes lung inflammation induced by LPS and LTA.
    van Zoelen MA; Verstege MI; Draing C; de Beer R; van't Veer C; Florquin S; Bresser P; van der Zee JS; te Velde AA; von Aulock S; van der Poll T
    Mol Immunol; 2011 Jul; 48(12-13):1468-76. PubMed ID: 21529952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation.
    Reiff SD; Mantel R; Smith LL; Greene JT; Muhowski EM; Fabian CA; Goettl VM; Tran M; Harrington BK; Rogers KA; Awan FT; Maddocks K; Andritsos L; Lehman AM; Sampath D; Lapalombella R; Eathiraj S; Abbadessa G; Schwartz B; Johnson AJ; Byrd JC; Woyach JA
    Cancer Discov; 2018 Oct; 8(10):1300-1315. PubMed ID: 30093506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial.
    Groeneveld GH; van der Reyden TJ; Joosten SA; Bootsma HJ; Cobbaert CM; de Vries JJC; Kuijper EJ; van Dissel JT
    J Antimicrob Chemother; 2019 Aug; 74(8):2385-2393. PubMed ID: 31106377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies.
    Aw A; Brown JR
    Drugs Aging; 2017 Jul; 34(7):509-527. PubMed ID: 28536906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endothelial protein C receptor impairs the antibacterial response in murine pneumococcal pneumonia and sepsis.
    Schouten M; de Boer JD; Kager LM; Roelofs JJ; Meijers JC; Esmon CT; Levi M; van 't Veer C; van der Poll T
    Thromb Haemost; 2014 May; 111(5):970-80. PubMed ID: 24401906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice.
    Nam HY; Nam JH; Yoon G; Lee JY; Nam Y; Kang HJ; Cho HJ; Kim J; Hoe HS
    J Neuroinflammation; 2018 Sep; 15(1):271. PubMed ID: 30231870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.